Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Pharmacodynamic Assays Market Report
2.
Stem Cell Research Products
3.
Poly(ADP-ribose) polymerase (PARP) Research Products
4.
Advances in Biopharmaceutical Technology in India
5.
Directory of Top 60 Biopharmaceutical Manufacturers in China
6.
Directory of Top 60 Biopharmaceutical Manufacturers in India
7.
Outsourcing for contract manufacturing services 2008-2023
8.
Osteoporosis & Bone Metabolism Disorders Market 2008-2023 Management Report
9.
Pfizer - Market Outlook for a Global Leader, 2008-2013
10.
Therapeutic Monoclonal Antibodies Report 2008-2023
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Autoimmune and Inflammation Rheumatoid Arthritis Drug Pipeline Report
3.
The Global Rheumatoid Arthritis Market Forecasts to 2012
4.
Neuro Stents & Coils Technology and Market Forecast
5.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
6.
Contract Research Annual Review 2008
7.
Worldwide Surgical Sealants, Glues and Wound Closure Market, 2007-2011
Stakeholder Opinions: Heart Failure - When drugs do not work
Advanced heart failure is a growing issue. Existing pharmacological strategies increase the survival rates of acute heart failure patients, providing a growing source of patients with advanced disease. In view of long waiting lists for heart transplantation and the growing lack of donors, cardiac resynchronization and mechanical circulatory support devices have demonstrated promising results.
Scope
What are the current definitions, diagnostic methods and treatment approaches of the early stages of the disease?
What are the main issues surrounding treatment approaches in the advanced stages of the disease?
What is the current role of cardiac resynchronization therapy in treatment of advanced heart failure?
What are the main non-pharmacological options as alternatives to heart transplantation in advanced heart failure?
Report Highlights
With no new drug therapies addressing advanced heart failure and existing pharmacological strategies failing to compensate a weakening heart, alternative, non-pharmacological solutions have to be found. In view of long waiting lists for heart transplantation and the growing shortage of donor hearts, the focus of treatment must shift onto devices.
Ventricular dyssynchrony is a well recognized problem in advanced stages of heart failure. Clinical trials investigating ventricular dyssynchrony cardiac resynchronization have demonstrated promising results. However, this technology provides only temporary, symptomatic relief and neither cures nor fully stops the progression of the disease.
In light of the growing shortage of donor hearts and failing pharmacological strategies, an artificial mechanical heart has been a long sought-after technology. Although the developments started decades ago, a fully implantable total artificial heart is still at the concept stage, with many years of research and development yet to come.
Reasons to Purchase
Understand current definitions, diagnostic methods and treatment approaches in advanced heart failure
Current dynamics and future trends of the technology developments treating advanced heart failure
Major technological and industry issues surrounding technological progress and new product development
17-Apr-08 Format: PDF & SlidePack Pages: 146
Table of Contents
Price: $3,800.00 / GBP1,976.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.